Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Cost of Revenue history
Currency unavailable · from the income statement
No Cost of Revenue data reported for this period type.
Cost of Revenue vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $7.98M USD | — | -65.2% | 11.3% | |
| LTM Jun 2026 | $559K USD | — | — | 7.9% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | — | |
| FY2025 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | -$101K USD | -104.8% | -1.1% | 44.9% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -102.4% | -33.1% | 9.6% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.